Praxis Precision Medicines (PRAX) Earnings Date & Reports
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
PRAX is expected to report earnings to fall 93.26% to -22 cents per share on March 13
Q4'23
Est.
$-0.22
Q1'25
Missed
by $0.42
Q4'24
Missed
by $0.15
Q3'24
Missed
by $0.76
Q2'24
Beat
by $0.57
The last earnings report on May 02 showed earnings per share of -328 cents, missing the estimate of -286 cents. With 250.81K shares outstanding, the current market capitalization sits at 781.15M.